Terms: = Thyroid cancer AND ATM, TELO1, 472, ENSG00000149311, TEL1, ATD, ATE, DKFZp781A0353, AT1, Q13315, MGC74674, ATDC, ATC, ATA AND Diagnosis
376 results:
1. The value of multimodal treatment in anaplastic thyroid cancer patients with distant metastasis.
Guo H; Lin H
BMC Surg; 2024 Mar; 24(1):79. PubMed ID: 38438944
[TBL] [Abstract] [Full Text] [Related]
2. MACE and Hyperthyroidism Treated With Medication, Radioactive Iodine, or thyroidectomy.
Peng CC; Lin YJ; Lee SY; Lin SM; Han C; Loh CH; Huang HK; Pearce EN
JAMA Netw Open; 2024 Mar; 7(3):e240904. PubMed ID: 38436957
[TBL] [Abstract] [Full Text] [Related]
3.
Sfreddo HJ; Koh ES; Zhao K; Swartzwelder CE; Untch BR; Marti JL; Roman BR; Dublin J; Wang RS; Xia R; Cohen JM; Xu B; Ghossein R; Givi B; Boyle JO; Tuttle RM; Fagin JA; Wong RJ; Morris LGT
Thyroid; 2024 Apr; 34(4):450-459. PubMed ID: 38407967
[No Abstract] [Full Text] [Related]
4. Progress in diagnosing and treating thyroid squamous cell carcinoma under the 5th edition of WHO classification.
Ding W; Gao X; Ran X
Front Endocrinol (Lausanne); 2023; 14():1273472. PubMed ID: 38303977
[TBL] [Abstract] [Full Text] [Related]
5. [Diagnostic Value of American thyroid Association Guidelines,American College of Radiology thyroid Imaging Reporting and Data System,and Chinese thyroid Imaging Reporting and Data System Alone and Combined With BRAF
Lin Y; Luo YK; Li J; Ren XY; Wang HW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Dec; 45(6):921-928. PubMed ID: 38173102
[TBL] [Abstract] [Full Text] [Related]
6. HOXD9/miR-451a/PSMB8 axis is implicated in the regulation of cell proliferation and metastasis via PI3K/AKT signaling pathway in human anaplastic thyroid carcinoma.
Zhong Y; Yu F; Yang L; Wang Y; Liu L; Jia C; Cai H; Yang J; Sheng S; Lv Z; Weng L; Wu B; Zhang X
J Transl Med; 2023 Nov; 21(1):817. PubMed ID: 37974228
[TBL] [Abstract] [Full Text] [Related]
7. [Personalized approach to anaplastic thyroid carcinoma].
Wächter S; Bartsch DK; Maurer E
Chirurgie (Heidelb); 2024 Mar; 95(3):192-199. PubMed ID: 37973622
[TBL] [Abstract] [Full Text] [Related]
8. Divergent Lineage Markers in Anaplastic thyroid Carcinoma.
Mneimneh WS; Asa SL
Am J Surg Pathol; 2024 Feb; 48(2):230-237. PubMed ID: 37972932
[TBL] [Abstract] [Full Text] [Related]
9. Characterization of the thyroid cancer Genomic Landscape by Plasma-Based Circulating Tumor DNA Next-Generation Sequencing.
Tarasova VD; Tsai J; Masannat J; Hernandez Prera JC; Hallanger Johnson J; Veloski C; Agosto Salgado S; McIver B; Drusbosky LM; Chung CH
Thyroid; 2024 Feb; 34(2):197-205. PubMed ID: 37962267
[No Abstract] [Full Text] [Related]
10. A Critical Assessment of Diagnostic Criteria for the Tall Cell Subtype of Papillary thyroid Carcinoma-How Much? How Tall? And When Is It Relevant?
Turchini J; Fuchs TL; Chou A; Sioson L; Clarkson A; Sheen A; Delbridge L; Glover A; Sywak M; Sidhu S; Gill AJ
Endocr Pathol; 2023 Dec; 34(4):461-470. PubMed ID: 37864666
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic Factors Improving ata Risk System and Dynamic Risk Stratification in Low- and Intermediate-Risk DTC Patients.
Maino F; Botte M; Dalmiglio C; Valerio L; Brilli L; Trimarchi A; Mattii E; Cartocci A; Castagna MG
J Clin Endocrinol Metab; 2024 Feb; 109(3):722-729. PubMed ID: 37804529
[TBL] [Abstract] [Full Text] [Related]
12. Changes in the outcomes of patients with anaplastic thyroid carcinoma over the past two decades.
Abdel-Rahman O; Ghosh S
Endocrine; 2024 Apr; 84(1):155-159. PubMed ID: 37804443
[TBL] [Abstract] [Full Text] [Related]
13. The Frequency of Differentiated thyroid cancer Recurrence in 2302 Patients With Excellent Response to Primary Therapy.
Pałyga I; Rumian M; Kosel A; Albrzykowski M; Krawczyk P; Kalwat A; Gąsior-Perczak D; Walczyk A; Kuchareczko A; Kopczyński J; Chrapek M; Góźdź S; Kowalska A
J Clin Endocrinol Metab; 2024 Jan; 109(2):e569-e578. PubMed ID: 37768152
[TBL] [Abstract] [Full Text] [Related]
14. A Prospective Multicenter Study Examining the Relationship Between thyroid cancer Treatment Outcomes and the Presence of Autoimmune thyroiditis.
De Leo S; D'Elia S; Grani G; Dondi F; Bertagna F; Puxeddu E; Morelli S; Piovesan A; Nervo A; Zatelli MC; Gagliardi I; Samà MT; Aimaretti G; Crocetti U; Massa M; Deandrea M; Retta F; Pagano L; Rossi M; Solaroli E; Pezzullo L; Chiofalo MG; Pontecorvi A; Lombardi CP; Antonelli A; Patrizio A; Messuti I; Magri F; Spiazzi G; Ceresini G; Bruno R; Sparano C; Centanni M; Crescenzi A; Tallini G; Marotta V; Madeo B; Mian C; Filetti S; Durante C; Fugazzola L
Thyroid; 2023 Nov; 33(11):1318-1326. PubMed ID: 37725571
[No Abstract] [Full Text] [Related]
15. AKT-independent signaling in PIK3CA-mutant thyroid cancer mediates resistance to dual SRC and MEK1/2 inhibition.
Rose MM; Nassar KW; Sharma V; Schweppe RE
Med Oncol; 2023 Sep; 40(10):299. PubMed ID: 37713162
[TBL] [Abstract] [Full Text] [Related]
16. Advances in the management of anaplastic thyroid carcinoma: transforming a life-threatening condition into a potentially treatable disease.
Califano I; Smulever A; Jerkovich F; Pitoia F
Rev Endocr Metab Disord; 2024 Feb; 25(1):123-147. PubMed ID: 37648897
[TBL] [Abstract] [Full Text] [Related]
17. Pediatric head and neck manifestations associated with multiple endocrine neoplasia syndromes.
Jellins T; Hill M; Prager JD; Francom CR; Chan CM; Schneider KW; Sharma A; Herrmann BW
Int J Pediatr Otorhinolaryngol; 2023 Oct; 173():111703. PubMed ID: 37604101
[TBL] [Abstract] [Full Text] [Related]
18. Recent advances in anaplastic thyroid cancer management.
Hamidi S; Maniakas A
Curr Opin Endocrinol Diabetes Obes; 2023 Oct; 30(5):259-264. PubMed ID: 37410453
[TBL] [Abstract] [Full Text] [Related]
19. BPAT-UNet: Boundary preserving assembled transformer UNet for ultrasound thyroid nodule segmentation.
Bi H; Cai C; Sun J; Jiang Y; Lu G; Shu H; Ni X
Comput Methods Programs Biomed; 2023 Aug; 238():107614. PubMed ID: 37244233
[TBL] [Abstract] [Full Text] [Related]
20. Identification and Validation of a Prognostic Signature Based on Methylation Profiles and Methylation-Driven Gene
Ju G; Zhang L; Guo W; Wang H; Zhang X; Mu Z; Sun Y; Sun D; Diao H; Miao S; Chen Y; Xing T; Liang J; Lin Y
Dis Markers; 2022; 2022():1686316. PubMed ID: 37223105
[TBL] [Abstract] [Full Text] [Related]
[Next]
